YMRC
SVA

Yorktown Management & Research Company’s Sinovac Biotech, Ltd SVA Stock Holding History

Yorktown Management & Research Company’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-149,786
Closed -$4.49K – 233
2023
Q3 		$4.49K Buy
149,786
+74,893
+100% +$2.25K 0.01% 211
2023
Q2 		$291K Buy
+74,893
New +$291K 0.31% 159
2022
Q4 		– Sell
-74,893
Closed -$485K – 229
2022
Q3 		$485K Hold
74,893
– – 0.63% 53
2022
Q2 		$485K Hold
74,893
– – 0.63% 51
2022
Q1 		$485K Hold
74,893
– – 0.41% 103
2021
Q4 		$485K Hold
74,893
– – 0.33% 129
2021
Q3 		$485K Hold
74,893
– – 0.36% 109
2021
Q2 		$485K Hold
74,893
– – 0.38% 104
2021
Q1 		$485K Hold
74,893
– – 0.4% 77
2020
Q4 		$485K Hold
74,893
– – 0.44% 78
2020
Q3 		$485K Hold
74,893
– – 0.45% 59
2020
Q2 		$485K Hold
74,893
– – 0.43% 51
2020
Q1 		$485K Hold
74,893
– – 0.49% 58
2019
Q4 		$485K Hold
74,893
– – 0.26% 131
2019
Q3 		$485K Hold
74,893
– – 0.26% 120
2019
Q2 		$485K Hold
74,893
– – 0.18% 150
2019
Q1 		$485K Hold
74,893
– – 0.16% 160
2018
Q4 		$520K Buy
74,893
+5,101
+7% +$37.3K 0.17% 144
2018
Q3 		$537K Buy
69,792
+5,147
+8% +$37.1K 0.16% 156
2018
Q2 		$482K Buy
+64,645
New +$509K 0.14% 157

Other funds holding SVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
TFA
Transamerica Financial Advisors St. Petersburg, Florida $1.17B AUM 23.36% 1-Year Est. Return
HI
Horizon Investments Charlotte, North Carolina $8.92B AUM 25.62% 1-Year Est. Return

Yorktown Management & Research Company's SVA Position: Q4 2023 in Review

Yorktown Management & Research Company sold out of Sinovac Biotech, Ltd (SVA) in Q4 2023, closing a stake of 149,786 shares — an estimated $4.49K sold.

Yorktown Management & Research Company first reported a position in SVA in Q2 2018 and held it in 20 quarters. The position peaked at $537K in Q3 2018. 8 funds tracked by Wall St. Rank hold SVA as of Q4 2023.

  • Yorktown Management & Research Company reported no remaining Sinovac Biotech, Ltd position as of Q4 2023 after selling out during the quarter.
  • Yorktown Management & Research Company sold 149,786 Sinovac Biotech, Ltd shares in Q4 2023, an estimated $4.49K.
  • Yorktown Management & Research Company first reported a position in Sinovac Biotech, Ltd in Q2 2018 and held it in 20 quarters.
  • Yorktown Management & Research Company's Sinovac Biotech, Ltd position peaked at $537K in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q4 2023.

Based on Yorktown Management & Research Company's 13F filing for Q4 2023, filed 26 Jan 2024.